Medications

Genetic test maker 23andMe launches drug R&D effort

Google-backed genetic testing company 23andMe is launching its own drug development unit, betting that it can translate its database of customer DNA information into novel medicines.

Diseases, Conditions, Syndromes

UTMB collaboration results in rapid Ebola test

University of Texas Medical Branch researchers who helped assess the effectiveness of a new rapid test kit to diagnose Ebola learned this week it has received emergency use authorization from the Food and Drug Administration.

Alzheimer's disease & dementia

Simple blood test can predict risk of dementia

Scientists at Rigshopitalet, Herlev Hospital and the University of Copenhagen identify a new biomarker that can predict the risk of developing dementia by way of a simple blood test. In the long term, this could mean better ...

Diseases, Conditions, Syndromes

US gives go-ahead to fast Ebola test

US authorities have given emergency authorisation to Swiss pharmaceutical firm Roche for an Ebola test that can take as little as three hours, the company said on Monday.

Medical research

Biomedical team creates 'nerve on a chip'

Michael J. Moore and J. Lowry Curley first met in the laboratory as professor and student. Now the two Tulane University researchers have started a new biomedical company that's winning praise and awards.

page 36 from 40